Modifiers of complement activation for prevention of antibody-mediated injury to allografts

scientific article published on August 2011

Modifiers of complement activation for prevention of antibody-mediated injury to allografts is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1097/MOT.0B013E3283489A5A
P698PubMed publication ID21681097

P50authorSolomon CohneyQ124167747
Peter HughesQ124167763
P433issue4
P921main subjectantibodyQ79460
P304page(s)425-433
P577publication date2011-08-01
P1433published inCurrent opinion in organ transplantationQ26842426
P1476titleModifiers of complement activation for prevention of antibody-mediated injury to allografts
P478volume16

Reverse relations

cites work (P2860)
Q36302476An Anti-C1s Monoclonal, TNT003, Inhibits Complement Activation Induced by Antibodies Against HLA
Q41849097Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury.
Q35876250Antibody-mediated rejection: an evolving entity in heart transplantation
Q33413394Antiphospholipid syndrome in renal transplantation
Q36503765Complement in Action: An Analysis of Patent Trends from 1976 Through 2011.
Q38168293Desensitization for prevention of chronic antibody-mediated rejection after kidney transplantation
Q61796690Endocan as a marker of microvascular inflammation in kidney transplant recipients
Q52310243Kidney Transplantation: The Challenge of Human Leukocyte Antigen and Its Therapeutic Strategies.
Q37433100Living donor renal transplantation in patients with antiphospholipid syndrome: A case report
Q36352514Mesenchymal stem cells are injured by complement after their contact with serum
Q39968188Off-label use of the expensive orphan drug eculizumab in France 2009-2013 and the impact of literature: focus on the transplantation field

Search more.